Table 2 Relative expression level of miRNAs in paired urine, serum, cervical scrapes, and tissue biopsies.

From: Urine miRNA signature as a potential non-invasive diagnostic and prognostic biomarker in cervical cancer

Sample

Pathology

miR-21-5p (FC ± SE)

P value

miR-145-5p (FC ± SE)

P value

miR-218-5p (FC ± SE)

P value

miR-34a-5p (FC ± SE)

P value

miR-155-5p (FC ± SE)

P value

miR-199a-5p (FC ± SE)

P value

Urine (n = 150) a

Pre-cancer (n = 50)

1.93 ± 0.9

 < 0.0001

0.32 ± 0.1

 < 0.0002

0.43 ± 0.1

 < 0.0003

0.41 ± 0.1

 < 0.0001

1.89 ± 0.2

 < 0.0001

1.51 ± 0.3

 < 0.0001

Cancer (n = 50)

2.42 ± 0.1

 < 0.0001

0.24 ± 0.5

 < 0.0002

0.32 ± 0.4

 < 0.0001

0.36 ± 0.2

 < 0.0001

2.27 ± 0.20

 < 0.0001

1.73 ± 0.1

 < 0.0001

Serum (n = 150) a

Pre-cancer (n = 50)

2.10 ± 0.20

 < 0.0001

0.15 ± 0.01

 < 0.0001

0.34 ± 0.09

 < 0.0001

0.27 ± 0.2

 < 0.0001

1.72 ± 0.1

 < 0.0001

1.81 ± 0.2

 < 0.0001

Cancer (n = 50)

2.72 ± 0.2

 < 0.012

0.18 ± 0.01

 < 0.0001

0.26 ± 0.03

 < 0.008

0.21 ± 0.10

 < 0.0001

2.16 ± 0.3

 < 0.0001

1.92 ± 0.2

 < 0.0001

Scrape (n = 90) b

Pre-cancer (n = 50)

2.3 ± 0.1

 < 0.0001

0.13 ± 0.1

 < 0.0001

0.28 ± 0.02

 < 0.0001

0.23 ± 0.01

 < 0.0001

1.94 ± 0.2

 < 0.0001

2.02 ± 0.3

 < 0.0001

Tissue biopsy (n = 70) c

Cancer (n = 40)

3.43 ± 0.3

 < 0.0001

0.12 ± 0.2

 < 0.0001

0.13 ± 0.2

 < 0.0001

0.14 ± 0.2

 < 0.0001

2.6 ± 0.4

 < 0.0001

2.2 ± 0.3

 < 0.0001

  1. FC fold change, SE standard error.
  2. aIncluding 50 urine and 50 serum samples from normal controls.
  3. bIncluding 40 cervical scrape from normal controls.
  4. cIncluding 30 paired adjacent non-malignant normal tissue.